Zentiva Acquires Heritage Brands from Aboca to Enhance Natural Health Solutions Across Europe

Zentiva Strengthens Its Position in Natural Health

Zentiva, a prominent player in the consumer healthcare sector, has recently announced the acquisition of five esteemed heritage brands from Aboca. This strategic move aims not only to enhance its product portfolio but also to expand access to well-known natural treatments across Europe.

With this acquisition, which is set to take effect on June 30, 2025, Zentiva will integrate products such as Propol2 EMF, Ruscoven, Serenil, Fisiodepur, and Finocarbo into its offerings. These brands are poised to bolster Zentiva's presence in key and rapidly growing categories of self-medication, specifically in respiratory, circulatory, and calm & sleep products. This aligns seamlessly with the increasing consumer demand for natural and sustainably sourced products, highlighting a significant market trend.

As highlighted by Steffen Saltofte, the CEO of Zentiva, “Natural self-care is no longer a niche; consumers, pharmacists, and healthcare systems increasingly expect it.” The integration of Aboca’s plant science expertise alongside Zentiva’s consumer healthcare reach is expected to accelerate the company’s growth trajectory across Western Europe. Currently, while the focus of this acquisition is on significant markets such as Italy, Spain, and France, it is also expanding to other European countries, including Portugal, Poland, Romania, and Greece.

This acquisition is more than just a business expansion; it is a strategic alignment with current health trends. The demand for products that promote natural health solutions continues to rise, making this move timely. By securing brands that are already recognized among consumers for their efficacy and quality, Zentiva is ensuring a stronger foothold in the competitive market of consumer healthcare. This acquisition is particularly pertinent as it adds substantial value to Zentiva’s portfolio, establishing leadership in key product categories alongside existing offerings.

Moreover, the acquisition underscores Zentiva's commitment to long-term growth. By integrating Aboca’s brands into its existing framework, Zentiva is not just looking to enhance its product range but is also setting the stage for future product expansions and geographic outreach.

About Zentiva

Founded on over 500 years of history, Zentiva is dedicated to ensuring health and well-being for all generations. The company develops and produces high-quality, affordable medicines, distributing them to over 100 million people in more than 30 countries across Europe and beyond. With four production sites and a robust network of external manufacturing partners, Zentiva prioritizes supply chain security and sustainable growth.

Backed by close to 5,000 employees, Zentiva is committed to creating a workplace where everyone feels valued and can contribute their best. The company aspires to continue bringing health and wellness to generations for at least another 500 years, reflecting its legacy and forward-looking vision.

With its latest acquisition of Aboca’s heritage brands, Zentiva stands at the forefront of a growing trend in the consumer healthcare market, promising future innovations and expanded access to natural health solutions for consumers throughout Europe.